Australian Medication Safety Services
  • Home
  • Advisory Services & Analysis
  • Expert Clinical Guidance
  • Education
  • Medical Writing
  • Research Design & Supervision
  • Medicolegal Consulting
  • Comments
Select Page

medicinebackground2

Mar 19, 2018

Recent Posts

  • Clinical trial reveals modest benefit for pharmacotherapy of methamphetamine use disorder.
  • Analysis of fatal adverse drug events encountered in the ED
  • COVID19 and remdesivir reactions.
  • Risk of atypical hip fracture increased with extended duration of treatment with bisphosphonates
  • Polypill delivers reduced cardiovascular events

Archives

  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018

Copyright © 2021 Australian Medication Safety Services | PO Box 179, Glen Osmond, South Australia 5064 | Email: admin@medsafetyaustralia.com.au

Website Design